• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

透析患者血管钙化的发病机制。

Pathogenesis of vascular calcification in dialysis patients.

作者信息

Ketteler Markus, Westenfeld Ralf, Schlieper Georg, Brandenburg Vincent

机构信息

Department of Nephrology and Clinical Immunology, University Hospital Aachen, Pauwelsstrasse 30, D-52057, Aachen, Germany.

出版信息

Clin Exp Nephrol. 2005 Dec;9(4):265-270. doi: 10.1007/s10157-005-0385-4.

DOI:10.1007/s10157-005-0385-4
PMID:16362152
Abstract

Soft-tissue and vascular calcification are highly prevalent in end-stage renal disease (ESRD). Vascular calcifications manifest as both medial and intimal calcification of arteries and are a hallmark of the accelerated atherosclerosis observed in uremia. The nature of vascular calcification is progressive, and is associated with arterial stiffness and increased cardiovascular mortality. Age, duration of dialysis, and diabetes mellitus are clear determinants of the severity of vascular calcification; however, more recently novel insights into the pathomechanisms of unwanted calcification processes have been gained. Disturbances of mineral metabolism such as hyperphosphatemia and hypercalcemia appear to contribute to progressive calcification, not only by passive precipitation but by actively inducing changes in vascular smooth muscle cell behavior toward an osteoblast-like phenotype. Specific calcium-regulatory proteins may act locally or systemically as calcification inhibitors. Dysregulations of calcification inhibitors, including fetuin-A, matrix Gla protein, osteoprotegerin, and pyrophosphates may also be pathophysiologically relevant factors in the context of uremic extraosseous calcification. In this context, low serum fetuin-A levels were recently found to be associated with increased mortality in cohorts of dialysis patients. This overview intends to summarize current knowledge of the scientific concepts involved in the pathogenesis of extraosseous calcification in ESRD.

摘要

软组织和血管钙化在终末期肾病(ESRD)中极为常见。血管钙化表现为动脉中层和内膜钙化,是尿毒症中加速动脉粥样硬化的一个标志。血管钙化的性质是渐进性的,与动脉僵硬和心血管死亡率增加相关。年龄、透析时间和糖尿病是血管钙化严重程度的明确决定因素;然而,最近对不必要钙化过程的发病机制有了新的认识。矿物质代谢紊乱,如高磷血症和高钙血症,似乎不仅通过被动沉淀,而且通过积极诱导血管平滑肌细胞向成骨细胞样表型转变,从而促进渐进性钙化。特定的钙调节蛋白可能在局部或全身作为钙化抑制剂起作用。钙化抑制剂的失调,包括胎球蛋白-A、基质Gla蛋白、骨保护素和焦磷酸盐,在尿毒症性骨外钙化的背景下也可能是病理生理学相关因素。在此背景下,最近发现透析患者队列中低血清胎球蛋白-A水平与死亡率增加有关。本综述旨在总结目前关于ESRD骨外钙化发病机制中涉及的科学概念的知识。

相似文献

1
Pathogenesis of vascular calcification in dialysis patients.透析患者血管钙化的发病机制。
Clin Exp Nephrol. 2005 Dec;9(4):265-270. doi: 10.1007/s10157-005-0385-4.
2
Novel insights into vascular calcification.血管钙化的新见解。
Kidney Int Suppl. 2006 Dec(105):S5-9. doi: 10.1038/sj.ki.5001996.
3
Deficiencies of calcium-regulatory proteins in dialysis patients: a novel concept of cardiovascular calcification in uremia.
Kidney Int Suppl. 2003 May(84):S84-7. doi: 10.1046/j.1523-1755.63.s84.21.x.
4
Vascular calcification in patients with end-stage renal disease.终末期肾病患者的血管钙化
Nephrol Dial Transplant. 2004 Aug;19 Suppl 5:V59-66. doi: 10.1093/ndt/gfh1058.
5
Vascular calcification in chronic kidney disease: pathogenesis and clinical implications.慢性肾脏病中的血管钙化:发病机制与临床意义
J Ren Nutr. 2009 Jan;19(1):78-81. doi: 10.1053/j.jrn.2008.10.015.
6
Fetuin-A and extraosseous calcification in uremia.胎球蛋白-A与尿毒症中的骨外钙化
Curr Opin Nephrol Hypertens. 2005 Jul;14(4):337-42. doi: 10.1097/01.mnh.0000172719.26606.6f.
7
Vascular calcification and disordered mineral metabolism in dialysis patients.透析患者的血管钙化与矿物质代谢紊乱
Semin Dial. 2007 Mar-Apr;20(2):139-43. doi: 10.1111/j.1525-139X.2007.00261.x.
8
[Experimental study of the mechanism for vascular calcification in chronic kidney disease].[慢性肾脏病血管钙化机制的实验研究]
Verh K Acad Geneeskd Belg. 2008;70(4):285-303.
9
Cardiovascular calcification in patients with end-stage renal disease: a century-old phenomenon.终末期肾病患者的心血管钙化:一个百年现象。
Kidney Int Suppl. 2002 Dec(82):S73-80. doi: 10.1046/j.1523-1755.62.s82.15.x.
10
Vascular calcification in dialysis patients: pathogenesis and consequences.透析患者的血管钙化:发病机制与后果
Am J Kidney Dis. 2003 Mar;41(3 Suppl 1):S96-9. doi: 10.1053/ajkd.2003.50094.

引用本文的文献

1
Comparison of CT acquired cardiac valvular calcification scores in hemodialysis and peritoneal dialysis patients undergoing open heart surgery.接受心脏直视手术的血液透析和腹膜透析患者CT获得的心脏瓣膜钙化评分比较。
Am Heart J Plus. 2022 Dec 1;25:100234. doi: 10.1016/j.ahjo.2022.100234. eCollection 2023 Jan.
2
The relationship between calcification inhibitor levels in chronic kidney disease and the development of atherosclerosis.慢性肾脏病患者中钙化抑制剂水平与动脉粥样硬化发展的关系。
Ren Fail. 2021 Dec;43(1):1349-1358. doi: 10.1080/0886022X.2021.1969248.
3
The Relationship Between Carotid Intima Media Thickness, Inflammation and GLA Rich Protein Levels in Chronic Kidney Disease.

本文引用的文献

1
Myocardial stiffness, cardiac remodeling, and diastolic dysfunction in calcification-prone fetuin-A-deficient mice.易发生钙化的胎球蛋白A缺乏小鼠的心肌僵硬度、心脏重塑和舒张功能障碍
J Am Soc Nephrol. 2005 Nov;16(11):3357-64. doi: 10.1681/ASN.2005040365. Epub 2005 Sep 21.
2
Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin.胎球蛋白-A水平低与心血管死亡相关:胎球蛋白编码基因变异的影响。
Kidney Int. 2005 Jun;67(6):2383-92. doi: 10.1111/j.1523-1755.2005.00345.x.
3
Role of calcification inhibitors in the pathogenesis of vascular calcification in chronic kidney disease (CKD).
慢性肾脏病中颈动脉内膜中层厚度、炎症与富含γ-亚麻酸蛋白水平之间的关系
Int J Gen Med. 2021 Sep 1;14:5119-5126. doi: 10.2147/IJGM.S331758. eCollection 2021.
4
Arterial Stiffness: A Focus on Vascular Calcification and Its Link to Bone Mineralization.动脉僵硬度:关注血管钙化及其与骨矿化的联系。
Arterioscler Thromb Vasc Biol. 2020 May;40(5):1078-1093. doi: 10.1161/ATVBAHA.120.313131. Epub 2020 Apr 2.
5
Research Progress on the Relationship between Coronary Artery Calcification and Chronic Renal Failure.冠状动脉钙化与慢性肾衰竭关系的研究进展。
Chin Med J (Engl). 2018 Mar 5;131(5):608-614. doi: 10.4103/0366-6999.226066.
6
Effect of high-protein meals during hemodialysis combined with lanthanum carbonate in hypoalbuminemic dialysis patients: findings from the FrEDI randomized controlled trial.血液透析期间高蛋白膳食联合碳酸镧对低白蛋白血症透析患者的影响:FrEDI随机对照试验的结果
Nephrol Dial Transplant. 2017 Jul 1;32(7):1233-1243. doi: 10.1093/ndt/gfw323.
7
Comparison between paricalcitol and active non-selective vitamin D receptor activator for secondary hyperparathyroidism in chronic kidney disease: a systematic review and meta-analysis of randomized controlled trials.帕立骨化醇与活性非选择性维生素D受体激动剂治疗慢性肾脏病继发性甲状旁腺功能亢进的比较:一项随机对照试验的系统评价和荟萃分析
Int Urol Nephrol. 2016 Apr;48(4):571-84. doi: 10.1007/s11255-015-1195-6. Epub 2016 Jan 9.
8
Imaging of haemodialysis: renal and extrarenal findings.血液透析的影像学检查:肾脏及肾外表现
Insights Imaging. 2015 Jun;6(3):309-21. doi: 10.1007/s13244-015-0383-3. Epub 2015 Feb 14.
9
Calcification of the thoracic aorta determined by three-dimensional computed tomography predicts cardiovascular complications in patients undergoing hemodialysis.通过三维计算机断层扫描测定的胸主动脉钙化可预测接受血液透析患者的心血管并发症。
Int Urol Nephrol. 2014 May;46(5):993-8. doi: 10.1007/s11255-013-0620-y. Epub 2013 Dec 7.
10
Impact of parathyroidectomy on cardiovascular outcomes and survival in chronic hemodialysis patients with secondary hyperparathyroidism. A retrospective study of 50 cases prior to the calcimimetics era.甲状旁腺切除术对慢性血液透析继发性甲状旁腺功能亢进患者心血管结局和生存的影响。一项对50例在拟钙剂时代之前的病例的回顾性研究。
BMC Surg. 2013;13 Suppl 2(Suppl 2):S4. doi: 10.1186/1471-2482-13-S2-S4. Epub 2013 Oct 8.
钙化抑制剂在慢性肾脏病(CKD)血管钙化发病机制中的作用。
Kidney Int. 2005 Jun;67(6):2295-304. doi: 10.1111/j.1523-1755.2005.00333.x.
4
The immunohistochemical localization of alpha2-Heremans-Schmid glycoprotein/fetuin-A (AHSG).α2-赫里曼斯-施密德糖蛋白/胎球蛋白-A(AHSG)的免疫组织化学定位。
Nephrol Dial Transplant. 2005 Apr;20(4):851-2. doi: 10.1093/ndt/gfh690.
5
Serum fetuin-A in nondialyzed patients with diabetic nephropathy: relationship with coronary artery calcification.未透析的糖尿病肾病患者血清胎球蛋白-A:与冠状动脉钙化的关系
Kidney Int. 2005 Mar;67(3):1070-7. doi: 10.1111/j.1523-1755.2005.00172.x.
6
Characteristics and performance of an immunosorbent assay for human matrix Gla-protein.
Clin Chim Acta. 2005 Jan;351(1-2):131-8. doi: 10.1016/j.cccn.2004.08.003.
7
Human vascular smooth muscle cells undergo vesicle-mediated calcification in response to changes in extracellular calcium and phosphate concentrations: a potential mechanism for accelerated vascular calcification in ESRD.人类血管平滑肌细胞会因细胞外钙和磷浓度的变化而发生囊泡介导的钙化:这是终末期肾病中血管钙化加速的一种潜在机制。
J Am Soc Nephrol. 2004 Nov;15(11):2857-67. doi: 10.1097/01.ASN.0000141960.01035.28.
8
Effects of cyclic intermittent etidronate therapy on coronary artery calcification in patients receiving long-term hemodialysis.环磷酰胺间歇疗法对长期血液透析患者冠状动脉钙化的影响。
Am J Kidney Dis. 2004 Oct;44(4):680-8.
9
Mineral metabolism, mortality, and morbidity in maintenance hemodialysis.维持性血液透析中的矿物质代谢、死亡率和发病率
J Am Soc Nephrol. 2004 Aug;15(8):2208-18. doi: 10.1097/01.ASN.0000133041.27682.A2.
10
Concerted regulation of inorganic pyrophosphate and osteopontin by akp2, enpp1, and ank: an integrated model of the pathogenesis of mineralization disorders.由碱性磷酸酶2(akp2)、胞外核酸焦磷酸酶/磷酸二酯酶1(enpp1)和ank协同调节无机焦磷酸和骨桥蛋白:矿化障碍发病机制的整合模型
Am J Pathol. 2004 Apr;164(4):1199-209. doi: 10.1016/S0002-9440(10)63208-7.